Intraarticular hemorrhage due to bevacizumab in a patient with metastatic colorectal cancer: a case report

INTRODUCTION: Bevacizumab is a monoclonal antibody against vascular endothelial growth factor. It is widely used in the treatment of metastatic colorectal cancer. It has some specific side effects including severe bleeding, wound healing problems, gastrointestinal perforation, proteinuria and hypert...

Descripción completa

Detalles Bibliográficos
Autores principales: Uysal, Mukremin, Goksu, Sema Sezgin, Coskun, Hasan Senol, Savas, Burhan, Ozdogan, Mustafa, Bozcuk, Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464779/
https://www.ncbi.nlm.nih.gov/pubmed/22776219
http://dx.doi.org/10.1186/1752-1947-6-188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464779/
https://www.ncbi.nlm.nih.gov/pubmed/22776219
http://dx.doi.org/10.1186/1752-1947-6-188

Ejemplares similares